{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&answeringDeptId=17&max-ddpModified.=2018-11-20T20%3A43%3A21.463Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&answeringDeptId=17&max-ddpModified.=2018-11-20T20%3A43%3A21.463Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&answeringDeptId=17&max-ddpModified.=2018-11-20T20%3A43%3A21.463Z&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&_page=0&answeringDeptId=17&max-ddpModified.=2018-11-20T20%3A43%3A21.463Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&answeringDeptId=17&max-ddpModified.=2018-11-20T20%3A43%3A21.463Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Ben+Bradley&answeringDeptId=17&max-ddpModified.=2018-11-20T20%3A43%3A21.463Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1010780", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1010780/answer", "answerText" : {"_value" : "
The current new-born screening programme in the United Kingdom screens for nine rare but serious conditions including phenylketonuria (PKU). To recognise rare conditions such as PKU, doctors and other healthcare professionals are expected to ensure their clinical knowledge remains up-to-date and to identify their ongoing learning needs as part of their continuing professional development. This activity should include taking account of new research and developments in guidance in relevant specialty areas, such as those produced by the National Institute for Health and Care Excellence or the Royal Colleges, to ensure that they can continue to provide high quality care to all patients.<\/p>
<\/p>
Steps to increase the awareness of rare diseases such as PKU are being taken through the implementation of the UK Strategy for Rare Diseases. The Strategy includes commitments to improving the lives of all patients affected by rare diseases including in areas of identification/ prevention and diagnosis and early intervention. The Government is committed to implementing the Strategy\u2019s commitments and in January 2018, the Department and NHS England published Implementation Plans setting out their actions for England.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-28T17:39:49.97Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Phenylketonuria"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness of Phenylketonuria.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4663", "label" : {"_value" : "Biography information for Ben Bradley"} } , "tablingMemberConstituency" : {"_value" : "Mansfield"} , "tablingMemberPrinted" : [{"_value" : "Ben Bradley"} ], "uin" : "193605"} , {"_about" : "http://data.parliament.uk/resources/1007853", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1007853/answer", "answerText" : {"_value" : "
Patients and the public already have the opportunity to submit peer reviewed, published evidence as part of the clinical commissioning policy and services specification development process and to comment on draft commissioning policies and service specifications during public consultation. An engagement report which summarises the views submitted is considered by the Clinical Priorities Advisory Group as part of their deliberations.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-22T15:14:05.03Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what progress has been made on creating a system whereby patient evidence can be considered as part of the specialised commissioning relative prioritisation process.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4663", "label" : {"_value" : "Biography information for Ben Bradley"} } , "tablingMemberConstituency" : {"_value" : "Mansfield"} , "tablingMemberPrinted" : [{"_value" : "Ben Bradley"} ], "uin" : "191991"} , {"_about" : "http://data.parliament.uk/resources/997209", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/997209/answer", "answerText" : {"_value" : "
Healthcare charities and other interested organisations have the opportunity to submit peer reviewed, published evidence, and to comment on draft clinical commissioning policies and service specifications that are being considered within the relative prioritisation process. They can do this either as a member of the policy working group, during stakeholder testing, or via a public consultation as per NHS England\u2019s Specialised Commissioning Service Development Policy.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-06", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-06T15:25:02.133Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether healthcare charities will be able to submit evidence as part of the specialised commissioning relative prioritisation process later this year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4663", "label" : {"_value" : "Biography information for Ben Bradley"} } , "tablingMemberConstituency" : {"_value" : "Mansfield"} , "tablingMemberPrinted" : [{"_value" : "Ben Bradley"} ], "uin" : "185103"} , {"_about" : "http://data.parliament.uk/resources/995615", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/995615/answer", "answerText" : {"_value" : "
Patients with tuberous sclerosis complex (TSC) have access to standard anti-epileptic drugs and whilst not licensed specifically for use in association with TSC, there is evidence that two thirds of patients will respond to treatment. A relatively new option specifically licensed for refractory epilepsy in TSC is everolimus (Votubia) which is due to be considered for prioritisation within the National Health Service in England in December as part of NHS England\u2019s biannual relative prioritisation process for specialised services.<\/p>
<\/p>
The life sciences sector deal, published last autumn, will ensure that the next wave of breakthrough treatments, innovative medical research and technologies are created in Britain. A key part of the deal was our commitment to improving patient access to innovation through the implementation of the Accelerated Access Review.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-05T15:40:37.927Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tuberous Sclerosis: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure patients with refractory epilepsy related to tuberous sclerosis complex are able to access new medicines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4663", "label" : {"_value" : "Biography information for Ben Bradley"} } , "tablingMemberConstituency" : {"_value" : "Mansfield"} , "tablingMemberPrinted" : [{"_value" : "Ben Bradley"} ], "uin" : "184448"} , {"_about" : "http://data.parliament.uk/resources/994541", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/994541/answer", "answerText" : {"_value" : "
This information is not held centrally. Through the Government\u2019s Better Care Fund, local areas set out plans which indicate the level of resource that will be dedicated to carer-specific support, including respite and carers\u2019 breaks. The exact breakdown on spend for carers\u2019 breaks is not collected centrally.<\/p>
<\/p>
Information covering other practical support available to carers from local authority\u2019s is not held centrally, either. However, the Care Act 2014 introduced important new rights for carers, for the first time putting them on the same footing as the people for whom they care. Carers have legal rights to an assessment of, and support for, their needs where eligible. Local authorities also have a wider duty to offer information and advice to all carers, including signposting the carer to support available locally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "dateOfAnswer" : {"_value" : "2018-11-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-01T13:14:37.327Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Carers: Nottinghamshire"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what information his Department holds on (a) respite care and (b) other practical support available to carers from local authorities in Nottinghamshire.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4663", "label" : {"_value" : "Biography information for Ben Bradley"} } , "tablingMemberConstituency" : {"_value" : "Mansfield"} , "tablingMemberPrinted" : [{"_value" : "Ben Bradley"} ], "uin" : "183952"} , {"_about" : "http://data.parliament.uk/resources/994558", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/994558/answer", "answerText" : {"_value" : "
We recognise that living with a long-term condition, such as rheumatoid arthritis, can also have an impact upon a person\u2019s mental wellbeing. The guideline Rheumatoid arthritis in adults: management, updated by the National Institute for Health and Care Excellence in 2018, sets out best practice in the diagnosis treatment care and support of people with rheumatoid arthritism. The guidance recommends that patients should be offered psychological interventions (for example, relaxation, stress management and cognitive coping skills to help them to adjust to living with their condition). Anyone suffering with a long-term condition who is suffering with their mental wellbeing should speak to their general practitioner in the first instance. The guidance can be accessed via the following link:<\/p>
<\/p>